Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
The Daily Biotech Pulse: Aldeyra Jumps Into COVID-19 Drug Fray, FDA Nod For Myriad's Companion Diagnostic Test
12:00am, Wednesday, 20'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 19)
ADC Therapeutics SA (NYSE:...
Deciphera's GIST Approval, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:CCXI)
08:21am, Tuesday, 19'th May 2020
Deciphera's Qinlock received FDA approval for GIST cancers. Chemocentryx reports below par kidney data. Moderna is up on positive COVID-19 data news.
Canaccord Genuity Maintains Buy on ChemoCentryx, Lowers Price Target to $58
12:00am, Tuesday, 19'th May 2020EN DIRECT DES MARCHES : Total, Vinci, Airbus, ADP, Seb, Neovacs, Compass, ThyssenKrupp, JC Penney...
12:50pm, Monday, 18'th May 2020
ChemoCentryx, Inc., (CCXI) and Vifor Fresenius Medical Care Renal Pharma (VFMCRP) today announced topline data from a forty-six (46) patient Phase II dose-ranging trial in the orphan kidney disorder,
Vifor: échec d'une collaboration clinique contre la glomérulosclérose | Zone bourse
05:22am, Monday, 18'th May 2020Analysts Have Just Cut Their ChemoCentryx, Inc. (NASDAQ:CCXI) Revenue Estimates By 11%
02:49pm, Saturday, 16'th May 2020
Market forces rained on the parade of ChemoCentryx, Inc. (NASDAQ:CCXI) shareholders today, when the analysts...
Integral Health Asset Management, LLC Buys Merck Inc, AstraZeneca PLC, Catalent Inc, Sells ...
12:00am, Friday, 15'th May 2020ChemoCentryx, Inc. (NASDAQ:CCXI) Just Reported And Analysts Have Been Cutting Their Estimates
10:53am, Thursday, 14'th May 2020
It's shaping up to be a tough period for ChemoCentryx, Inc. (NASDAQ:CCXI), which a week ago released some...
JP Morgan Maintains Overweight on ChemoCentryx, Raises Price Target to $64
12:00am, Thursday, 14'th May 2020ChemoCentryx, Inc. (CCXI) CEO Dr. Thomas Schall on Q1 2020 Results - Earnings Call Transcript
07:35pm, Wednesday, 13'th May 2020
ChemoCentryx, Inc. (NASDAQ:CCXI) Q1 2020 Results Conference Call May 11, 2020 05:00 PM ET Company Participants Bill Slattery - IR, Burns McClellan Dr. Thomas Sc
